(-0.03%) 5 211.25 points
(-0.17%) 39 127 points
(0.04%) 18 195 points
(0.54%) $79.42
(0.73%) $2.20
(0.43%) $2 332.40
(1.90%) $28.13
(-0.15%) $983.10
(-0.03%) $0.930
(0.04%) $10.90
(0.06%) $0.801
(1.02%) $92.68
Quarter results today
(bmo 2024-05-09)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States...
Stats | |
---|---|
今日成交量 | 14 934.00 |
平均成交量 | 23 078.00 |
市值 | 36.80M |
EPS | $0 ( 2024-03-28 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.650 |
ATR14 | $0.0500 (1.68%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-03 | Milligan Sandra | Buy | 30 000 | EMPLOYEE STOCK OPTION (RIGHT TO BUY) |
2024-04-01 | Milligan Sandra | Buy | 0 | |
2024-02-15 | Sandford Nicole | Buy | 30 000 | Employee stock option (right to buy) |
2024-02-14 | Hombeck Torsten | Buy | 20 000 | Employee stock option (right to buy) |
2024-02-14 | Merchant Minh Hoang | Buy | 11 000 | Employee stock option (right to buy) |
INSIDER POWER |
---|
97.47 |
Last 89 transactions |
Buy: 4 309 531 | Sell: 195 424 |
Aspira Women's Health 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Aspira Women's Health 财务报表
Annual | 2023 |
营收: | $9.15M |
毛利润: | $5.26M (57.48 %) |
EPS: | $-1.810 |
FY | 2023 |
营收: | $9.15M |
毛利润: | $5.26M (57.48 %) |
EPS: | $-1.810 |
FY | 2022 |
营收: | $8.18M |
毛利润: | $4.32M (52.77 %) |
EPS: | $-41.66 |
FY | 2021 |
营收: | $6.81M |
毛利润: | $3.06M (44.95 %) |
EPS: | $-0.280 |
Financial Reports:
No articles found.
Aspira Women's Health
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。